Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Safety and Feasibility of Electrical Isolation of the Superior Vena Cava in Addition to Pulmonary Vein Ablation for Paroxysmal Atrial Fibrillation Using the Cryoballoon: the SAFE-SVC Study.

NCT03190096 is registered in ClinicalTrials.gov with Ettore Sansavini Health Science Foundation as lead sponsor.

NCT NCT03190096
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03190096 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Safety and Feasibility of Electrical Isolation of the Superior Vena Cava in Addition to Pulmonary Vein Ablation for Paroxysmal Atrial Fibrillation Using the Cryoballoon: the SAFE-SVC Study.
Lead sponsor
Ettore Sansavini Health Science Foundation
Phase
Observational
Overall status
Unknown status
Start date
June 7, 2017
Completion date
June 30, 2019
Enrollment
120 (estimated)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

paroxysmal atrial fibrillation